Lack of a Synergistic Effect of a Non-Viral ALS Gene Therapy Based on BDNF and a TTC Fusion Molecule

Orphanet Journal of Rare Diseases - United Kingdom
doi 10.1186/1750-1172-6-10
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Single-Molecule Analysis of a Viral Fusion Protein Illuminates a Fusion-Active Intermediate State

Cell
BiochemistryGeneticsMolecular Biology
2018English

Applications and Implications of Viral and Non Viral Vectors in Gene Therapy

Open Access Journal of Pharmaceutical Research
2019English

Synergistic Effect of Rifamycin Derivatives and Amphotericin B on Viral Transformation of a Murine Cell Line

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1972English

pEPI for Gene Therapy Non Viral Episomes and Their Application in Somatic Gene Therapy

Journal of Cell Science & Therapy
2013English

Non-Viral Gene Therapy for Spinal Cord Regeneration

Drug Discovery Today
Drug DiscoveryPharmacology
2012English

Effect of a Multidisciplinary Amyotrophic Lateral Sclerosis (ALS) Clinic on ALS Survival: A Population Based Study, 1996-2000

Journal of Neurology, Neurosurgery and Psychiatry
PsychiatryMental HealthNeurologySurgery
2003English

Current Status of Non-Viral Gene Therapy for CNS Disorders

Expert Opinion on Drug Delivery
Pharmaceutical Science
2016English

A Brief Account of Viral Vectors and Their Promise for Gene Therapy

Gene Therapy
Molecular MedicineGeneticsMolecular Biology
2017English

Establishing Polymeric Transfection as a Non-Viral, Non-Toxic Method for Gene Therapy in the Prevention of Vascular Disease

Journal of Vascular Surgery
SurgeryCardiovascular MedicineCardiology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy